Wilson Sonsini advised Faeth Therapeutics on the deal.Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led by…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
